Acquired bleeding disorders through antithrombotic therapy: the implications for dental practitioners

被引：1

作者：

Al-Ansari, Anmar ^{[1
]}

机构：

[1] Forth Valley Royal Hosp, Oral & Maxillofacial Surg, Stirling Rd, Larbert FK5 4WR, Scotland

来源：

BRITISH DENTAL JOURNAL | 2020年 / 229卷 / 11期

关键词：

LOW-DOSE ASPIRIN; ORAL ANTICOAGULANTS; MANAGEMENT CONSIDERATIONS; WITHDRAWAL; WARFARIN; COAGULOPATHIES; PREVENTION; GUIDELINES; DABIGATRAN; CESSATION;

D O I：

10.1038/s41415-020-2399-4

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

Antithrombotic medications are one of the most common causes of an acquired bleeding disorder. The majority of these medications are administered orally fora variety of clinical indications. It is important that dental surgeons are aware of these medications, their mechanisms of action and how they can influence the dental management of patients, particularly when undertaking procedures which carry a risk of bleeding.

引用

页码：729 / 734

页数：6

共 48 条

[1] Evaluation of dental extractions, suturing and INR on postoperative bleeding of patients maintained on oral anticoagulant therapy [J].

Al-Mubarak, S. ;

Al-Ali, N. ;

Abou Rass, M. ;

Al-Sohail, A. ;

Robert, A. ;

Al-Zoman, K. ;

Al-Suwyed, A. ;

Ciancio, S. .

BRITISH DENTAL JOURNAL, 2007, 203 (07) :E15-E15

[2] Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease Report of the Guideline Development Subcommittee of the American Academy of Neurology [J].

Armstrong, Melissa J. ;

Gronseth, Gary ;

Anderson, David C. ;

Biller, Jose ;

Cucchiara, Brett ;

Dafer, Rima ;

Goldstein, Larry B. ;

Schneck, Michael ;

Messe, Steven R. .

NEUROLOGY, 2013, 80 (22) :2065-2069

[3]

AstraZeneca UK Limited, 2015, BRIL SUMM PROD CHAR

[4]

AurobindoPharma-MilpharmLtd, 2013, CLOP BIS SUMM PROD C

[5] Safety of local anaesthesia in dental patients taking oral anticoagulants: is it still controversial? [J].

Bajkin, Branislav V. ;

Todorovic, Ljubomir M. .

BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2012, 50 (01) :65-68

[6]

Bayer Schering Pharma AG, 2008, XAR SUMM PROD CHAR

[7] The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans [J].

Blech, Stefan ;

Ebner, Thomas ;

Ludwig-Schwellinger, Eva ;

Stangier, Joachim ;

Roth, Willy .

DRUG METABOLISM AND DISPOSITION, 2008, 36 (02) :386-399

[8]

Boehringer Ingelheim Limited, 2008, PRAD SUMM PROD

[9] Protocol in managing oral surgical patients taking dabigatran [J].

Breik, O. ;

Cheng, A. ;

Sambrook, P. J. ;

Goss, A. N. .

AUSTRALIAN DENTAL JOURNAL, 2014, 59 (03) :296-301

[10] Low-dose aspirin for secondary cardiovascular prevention -: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation -: review and meta-analysis [J].

Burger, W ;

Chemnitius, JM ;

Kneissl, GD ;

Rücker, G .

JOURNAL OF INTERNAL MEDICINE, 2005, 257 (05) :399-414

← 1 2 3 4 5 →